Efficacies of Vesicular and Free Sodium Stibogluconate Formulations against Clinical Isolates of Leishmania donovani

Por Carter, K. C., Mullen, A. B., Sundar, S., Kenney, R. T.
Publicado em 2001

The Cured Immune Phenotype Achieved by Treatment of Visceral Leishmaniasis in the BALB/c Mouse with a Nonionic Surfactant Vesicular Formulation of Sodium Stibogluconate Does Not P...

Por Carter, K. C., Baillie, A. J., Mullen, A. B.
Publicado em 1999

Visceral Leishmaniasis in the BALB/c Mouse: A Comparison of the Efficacy of a Nonionic Surfactant Formulation of Sodium Stibogluconate with Those of Three Proprietary Formulations...

Por Mullen, A. B., Baillie, A. J., Carter, K. C.
Publicado em 1998

Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.

Por Mullen, A B, Carter, K C, Baillie, A J
Publicado em 1997

The In Vivo Susceptibility of Leishmania donovani to Sodium Stibogluconate Is Drug Specific and Can Be Reversed by Inhibiting Glutathione Biosynthesis

Por Carter, K. C., Sundar, S., Spickett, C., Pereira, O. C., Mullen, A. B.
Publicado em 2003

Resistance of Leishmania donovani to Sodium Stibogluconate Is Related to the Expression of Host and Parasite γ-Glutamylcysteine Synthetase

Por Carter, K. C., Hutchison, S., Henriquez, F. L., Légaré, D., Ouellette, M., Roberts, C. W., Mullen, A. B.
Publicado em 2006

Pharmacokinetics, Toxicities, and Efficacies of Sodium Stibogluconate Formulations after Intravenous Administration in Animals

Por Nieto, J., Alvar, J., Mullen, A. B., Carter, K. C., Rodríguez, C., San Andrés, M. I., San Andrés, M. D., Baillie, A. J., González, F.
Publicado em 2003